Triazole glycolate oxidase inhibitors

A compound according to Formula Ia:

• or a pharmaceutically acceptable salt thereof, wherein:
• L is ;
• the dashed line connected to Z1 is a single bond, Z1 is NR5, the dashed line connected to Z2 is a double bond, and Z2 is N, or
• the dashed line connected to Z1 is a double bond, Z1 is N, the dashed line connected to Z2 is a single bond, and Z2 is NR5;
• R1 is selected from H, unsubstituted C1-6 alkyl, substituted C1-6 alkyl, —(C1—6 alkylene)—OC(O)—(C1—6 alkyl), and —(C1—6 alkylene)—OC(O)—(C1—6 alkoxy);
• R2 is selected from the group consisting of H and halogen;
• R3 is selected from the group consisting of H, halogen, C1-12 alkyl, and C1-12 alkoxy ;
• R4 is selected from the group consisting of C6-12 aryl and 5- to 12-membered heteroaryl;
• R4 is substituted with one or more R4a;
• each R4a is independently C3-8 halocycloalkyl ;
• and
• R5 is selected from the group consisting of H, unsubstituted C1-6 alkyl, substituted C1-6 alkyl, C2-7 acyl, —(C1—6 alkylene)—OC(O)—(C1—6 alkyl), and —(C1—6 alkylene)—OC(O)—(C1—6 alkoxy);
• .